|
|
|
|
||
|
||
|
Vol. 7, Nos. 1-43, pp. 1-1268 Jan. 2 -- Oct. 30, 2009 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Earl v. Eli Lilly and Co. (E.D.N.Y.), 1071
Ebel v. Eli Lilly and Co. (5th Cir.), 402 Edelstein; U.S. v. (E.D. Ky.), 1105 Eisai Co. v. Teva Pharms. USA Inc. (D.N.J.), 796 Elan Corp. PLC v. Andrx Pharms. Inc. (S.D. Fla.), 284 Elan Pharma Intl. Ltd. v. Alcon Labs. Ltd. (E.D. Tex.), 119 Elan Pharma Intl. Ltd. v. Biogen Inc. (S.D.N.Y.), 1029 Eli Lilly and Co. v. Actavis Elizabeth LLC (D.N.J.), 609 Eli Lilly and Co.; Ariad Pharms. Inc. v. (Fed. Cir.), 172; 399; 988 Eli Lilly and Co.; Clark v. (E.D.N.Y.), 677 Eli Lilly and Co.; Connecticut v. (E.D.N.Y.), 1131 Eli Lilly and Co.; Earl v. (E.D.N.Y.), 1071 Eli Lilly and Co.; Ebel v. (5th Cir.), 402 Eli Lilly and Co.; Leggett v. (E.D.N.Y.), 587; 768 Eli Lilly and Co.; Morrison v. (E.D.N.Y.), 768 Eli Lilly and Co.; Neal v. (E.D.N.Y.), 768 Eli Lilly and Co.; Ortenzio v. (E.D.N.Y.), 677 Eli Lilly and Co.; Pruett v. (E.D.N.Y.), 995 Eli Lilly and Co.; South Carolina v. (S.C. Cir. Ct.), 1249 Eli Lilly and Co.; Sun Pharms. Indus. Ltd. v. (E.D. Mich.), 962 Eli Lilly and Co. v. Teva Pharms. USA Inc. (Fed. Cir.), 225; (S.D. Ind.), 281; 496; 1130 Eli Lilly and Co.; U.S. v. (E.D. Pa.), 93 Endo Pharm. Inc. v. Actavis South Atl. LLC (D.N.J.), 230 Eon Labs Inc.; King Pharms. Inc. v. (E.D.N.Y.), 92 Epogen & Aranesp Off-Label Mktg. & Sales Practices Litig., In re (C.D. Cal.), 37; 730 Eufaula Drugs Inc. v. TDI Managed Care Servs. Inc. (M.D. Ala.), 312 Eurand Inc. v. Mylan Pharms. Inc. (D. Del.), 1192 EUSA Pharma (US) Inc. v. Innocoll Pharms. Ltd. (E.D. Pa.), 149 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
